Clinical Trial Update: The ONE Study UK Treg Trial [Phase 1, Phase 2]

View source ↗

Summary

The ONE Study UK Treg Trial, a Phase 1/2 investigation of regulatory T cell therapy for end-stage renal disease, has completed its trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: End-stage Renal Failure | Phase 1, Phase 2 | Status: COMPLETED